NCT05955105 2024-05-21A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesInnolake BiopharmPhase 1/2 Recruiting200 enrolled
NCT04137900 2024-02-05Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Unknown499 enrolled
NCT05798533 2023-07-10Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)BGI, ChinaPhase 1 Unknown6 enrolled